Shoemaker W C, Wo C C
Los Angeles County, University of Southern California Medical Center 90033, USA.
Vox Sang. 1998;74 Suppl 2:69-74. doi: 10.1111/j.1423-0410.1998.tb05399.x.
Circulatory deficiencies and the effectiveness of transfusion and fluid therapy may be evaluated by invasive and noninvasive monitoring after high risk surgery, hemorrhage, trauma, and sepsis in the ED, OR, and ICU. Earlier recognition and therapy of circulatory problems in emergency and critically ill patients to achieve optimal goals empirically defined by the survivors' patterns is recommended to improve outcome. WB, Prbc, and colloids markedly and statistically significantly improved pressure, flow, and tissue perfusion and best achieved these goals. Noninvasive monitoring may be used in the ED and OR shortly after admission to identify circulatory deficiencies and to titrate therapy, or they may be used initially as the front-end of subsequent invasive monitoring.
在急诊科、手术室和重症监护病房对高危手术、出血、创伤和脓毒症患者进行有创和无创监测，可评估循环系统缺陷以及输血和液体疗法的效果。建议对急诊和危重症患者的循环问题进行早期识别和治疗，以根据幸存者模式经验性确定的最佳目标，从而改善预后。全血、浓缩红细胞和胶体显著且在统计学上显著改善了血压、血流和组织灌注，并最能实现这些目标。入院后不久，可在急诊科和手术室使用无创监测来识别循环系统缺陷并调整治疗，或者它们可最初用作后续有创监测的前端。
